sn 38 has been researched along with rifampin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abbott, KL; Karthikeyan, C; Lee, C; Manne, U; Mittal, R; Moore, J; Narayanan, NK; Pondugula, SR; Suswam, EA; Tiwari, AK; Trivedi, P | 1 |
1 other study(ies) available for sn 38 and rifampin
Article | Year |
---|---|
IND-2, a pyrimido[1″,2″:1,5]pyrazolo[3,4-b]quinoline derivative, circumvents multi-drug resistance and causes apoptosis in colon cancer cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Colonic Neoplasms; Dogs; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; HCT116 Cells; HEK293 Cells; Hep G2 Cells; Humans; Madin Darby Canine Kidney Cells; MCF-7 Cells; Mice; Pyrimidines; Quinolines | 2015 |